[go: up one dir, main page]

AR042107A1 - Composiciones dieteticas - Google Patents

Composiciones dieteticas

Info

Publication number
AR042107A1
AR042107A1 ARP030104300A ARP030104300A AR042107A1 AR 042107 A1 AR042107 A1 AR 042107A1 AR P030104300 A ARP030104300 A AR P030104300A AR P030104300 A ARP030104300 A AR P030104300A AR 042107 A1 AR042107 A1 AR 042107A1
Authority
AR
Argentina
Prior art keywords
serum protein
dietary compositions
diet compositions
palatine
lecithins
Prior art date
Application number
ARP030104300A
Other languages
English (en)
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of AR042107A1 publication Critical patent/AR042107A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/068—Particular types of cheese
    • A23C19/076—Soft unripened cheese, e.g. cottage or cream cheese
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/34—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)

Abstract

Composiciones dietéticas que comprenden como ingredientes esenciales: hidrolizados de proteínas séricas; lecitinas y aceites y grasas ricos en ácido oleico, que permiten mejorar el metabolismo de los lípidos: y palatinosa que posee un efecto economizador de insulina. Aún más, se encontró que el hidrolizado de proteínas séricas incluido en las composiciones dietéticas suprimía la producción inducida por endotoxinas de TNF-a e interleuquina 6 en macrófagos.
ARP030104300A 2002-11-22 2003-11-20 Composiciones dieteticas AR042107A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002339948 2002-11-22

Publications (1)

Publication Number Publication Date
AR042107A1 true AR042107A1 (es) 2005-06-08

Family

ID=32375794

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104300A AR042107A1 (es) 2002-11-22 2003-11-20 Composiciones dieteticas

Country Status (16)

Country Link
US (2) US7563458B2 (es)
EP (1) EP1575379B1 (es)
JP (3) JP2006515287A (es)
KR (1) KR101038354B1 (es)
CN (1) CN100393243C (es)
AR (1) AR042107A1 (es)
AT (1) ATE468762T1 (es)
BR (1) BR0316512A (es)
CA (1) CA2506603C (es)
DE (1) DE60332760D1 (es)
DK (1) DK1575379T3 (es)
ES (1) ES2344640T3 (es)
MY (1) MY169519A (es)
NZ (1) NZ540775A (es)
TW (1) TWI317636B (es)
WO (1) WO2004047566A1 (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094848A1 (ja) * 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
US20110274755A1 (en) * 2004-04-22 2011-11-10 Smith Howard J Supportive treatment of liver disease
US20100222259A1 (en) * 2004-07-09 2010-09-02 Hidekazu Arai Compositions for enhancing the production of PPAR and/or PPAR-associated factors
PT1901620T (pt) 2005-05-31 2020-09-28 Arla Foods Amba Frações de leite enriquecido com fosfatidiliserina para a formulação de alimentos funcionais
KR101375933B1 (ko) * 2005-06-24 2014-03-18 카오카부시키가이샤 야채즙 및/또는 과즙 함유 용기 담긴 음료
DE102006017611A1 (de) * 2006-04-12 2007-10-25 Südzucker AG Mannheim/Ochsenfurt Kohlenhyrathaltige Sportgetränke
ZA200808292B (en) * 2006-04-21 2010-02-24 Unilever Plc Oxidation-stable granulate containing unsaturated fatty acids
DK2046362T3 (da) * 2006-06-15 2013-07-01 Murray Goulburn Coop Co Ltd Formulering omfattende valleprotein og hydrolysater til forbedring af muskelrekuperation
DE102007009029A1 (de) * 2007-02-23 2008-09-04 Südzucker AG Mannheim/Ochsenfurt Niedrig-glykämische Mischungen
US9420807B2 (en) 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
EP2178539A4 (en) * 2007-08-17 2011-05-04 Murray Goulburn Coop Co Ltd PHOSPHOLIPIDE COMPREHENSIVE COMPOSITIONS
JP4941666B2 (ja) * 2007-10-19 2012-05-30 松谷化学工業株式会社 食物繊維強化剤及び食品
US8361534B2 (en) 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
JP2011507518A (ja) * 2007-12-20 2011-03-10 アボット・ラボラトリーズ 安定な栄養粉末
FI122252B (fi) * 2008-01-04 2011-10-31 Valio Oy Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä
US20110130637A1 (en) * 2008-03-20 2011-06-02 University Of Dundee Protein product for modifying cardiovascular health
DE102008032828A1 (de) * 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
KR20110107375A (ko) * 2009-01-19 2011-09-30 뉴트리 가부시키가이샤 저농도의 영양 조성물
WO2010097484A2 (es) * 2009-02-25 2010-09-02 Productos Carnicos Elaborados Con Aceite De Oliva Virgen, S.L. Composición alimentaria
CN102378581A (zh) 2009-04-02 2012-03-14 诺维信公司 用于制备基于乳的蛋白质水解产物的方法
JP5946642B2 (ja) * 2009-11-30 2016-07-06 株式会社明治 小腸に良い栄養組成物
PL2332428T3 (pl) * 2009-12-04 2015-02-27 Mjn Us Holdings Llc Formulacja odżywcza zawierająca hydrolizat zawierający peptydy mleka krowiego i/lub pochodzące z niego peptydy do indukowania tolerancji
JP5779348B2 (ja) * 2010-12-27 2015-09-16 日油株式会社 酸性液状栄養組成物
CA2823970C (en) 2011-01-06 2019-03-05 Holista Biotech Sdn. Bhd. Reduced sodium composition
US9352495B1 (en) * 2011-03-14 2016-05-31 HSP Holdings, LLC Barrier release agent
FR2976399B1 (fr) 2011-06-09 2013-05-31 Veolia Proprete Procede de deconstruction au moins partielle d'un ecran plat de visualisation
CN103957720B (zh) * 2011-11-30 2016-05-25 株式会社明治 肠内菌群改善用营养组合物
US8927601B2 (en) 2011-12-20 2015-01-06 National Dong Hwa University Uses of N-butylidenephthalide in treating a liver injury and improving liver function
TWI472519B (zh) * 2011-12-20 2015-02-11 Nat Univ Dong Hwa 含正－亞丁基苯酞之醫藥組成物用於治療肝損傷及改善肝功能
EP2674159B1 (de) * 2012-06-15 2016-04-27 Phrontier S.A.R.L. Pharmazeutische Zusammensetzung für die Leber-Regeneration
JP6277957B2 (ja) * 2012-08-20 2018-02-14 味の素株式会社 栄養組成物
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
SG11201600657RA (en) * 2013-07-31 2016-02-26 Meiji Co Ltd Nutritional composition for inhibiting growth of tumor
DE102013018267A1 (de) * 2013-10-31 2015-04-30 Jan Berg Quarkhaltige Zusammensetzung
ES2544153B1 (es) * 2014-02-24 2016-06-06 Ntd Labs, S.L. Uso de un hidrolizado de caseína como agente antiviral
CN104082656B (zh) * 2014-06-12 2017-04-12 广东省农业科学院蚕业与农产品加工研究所 一种适合肝病病人的营养膳及其制作方法
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法
RU2694195C2 (ru) 2014-09-30 2019-07-09 Нестек С.А. Питательная композиция для применения при активации формирования и/или регенерации кишечника и/или печени
ES2841939T3 (es) * 2015-03-30 2021-07-12 Nestle Sa Hidrolizados de proteínas a base de leche y composiciones elaboradas mediante éstos
DK3355701T3 (da) * 2015-10-01 2021-01-25 Frieslandcampina Nederland Bv Væskeformig ernæringssammensætning, der omfatter micellært kasein og hydrolyseret valleprotein
CN105520019A (zh) * 2015-11-25 2016-04-27 广西巴马活益生生物科技有限公司 一种多菌种微生物复合功能型饮料制剂及其制备方法
SG11201804602SA (en) * 2015-12-03 2018-06-28 Meiji Co Ltd Nutritional composition
SG11201805957QA (en) 2016-01-22 2018-08-30 Meiji Co Ltd Composition for inhibiting endotoxin entry into blood
JP6842244B2 (ja) * 2016-05-10 2021-03-17 花王株式会社 アイスクリーム類
JP6325036B2 (ja) * 2016-08-19 2018-05-16 株式会社明治 抗がん剤に起因する末梢神経障害を改善するための組成物
KR101837299B1 (ko) 2016-10-21 2018-03-09 김나연 발효 유청단백질의 제조방법 및 발효 유청단백질
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
JP7195746B2 (ja) * 2018-03-20 2022-12-26 株式会社明治 炎症性貧血処置のための組成物
CN108707327A (zh) * 2018-06-14 2018-10-26 湖北文理学院 复合材料及其制备方法
FR3083981B1 (fr) 2018-07-20 2021-01-15 Semiocare Sas Compositions a usage cosmetique et dermatologique
CN110663960A (zh) * 2019-08-23 2020-01-10 北京康爱营养医学研究院 一种营养组合物及其制备方法、应用
KR102690070B1 (ko) 2021-02-26 2024-07-31 (주)서울에프엔비 항산화 기능성이 우수한 유청단백질 가수분해물이 첨가된 발효유 및 그 제조방법
CN114271480B (zh) * 2021-12-31 2023-10-20 烟台大学 一种高稳定性终末期阶段肾病全营养食品乳剂及其制备工艺
KR102821317B1 (ko) 2022-05-27 2025-06-17 (주)서울에프엔비 피부 노화 예방 기능성 요구르트의 제조방법 및 이를 이용하여 제조한 요구르트 제품

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600588A (en) 1980-08-20 1986-07-15 Ernster John H Milk protein hydrolysate and process of preparation
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
EP0312612B1 (en) * 1987-05-01 1993-03-24 Otsuka Pharmaceutical Co., Ltd. Nutritive emulsion
DK0421309T4 (da) 1989-10-02 2003-04-22 Associated British Foods Plc Proteinhydrolysater
JPH03167723A (ja) 1989-11-27 1991-07-19 Matsushita Electric Works Ltd サーモスイッチ
US5198250A (en) 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
ATE146657T1 (de) 1991-05-31 1997-01-15 Danmark Protein As Verfahren zur herstellung eines molkeprotein- hydrolysates
JPH0515339A (ja) * 1991-07-10 1993-01-26 Terumo Corp タンパク質様組成物および高度侵襲用栄養剤ならびに肝疾患用栄養剤
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
JP3396090B2 (ja) * 1994-08-18 2003-04-14 日東薬品工業株式会社 粉末栄養組成物
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
MY129566A (en) * 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6998259B1 (en) * 1999-05-20 2006-02-14 Davisco Foods International Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
JP2001233783A (ja) * 2000-02-21 2001-08-28 Terumo Corp 術前栄養剤
JP2001247474A (ja) * 2000-03-07 2001-09-11 Snow Brand Milk Prod Co Ltd 肝疾患予防及び／又は治療剤
NZ506866A (en) * 2000-09-11 2003-05-30 New Zealand Dairy Board Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease
JP2002226394A (ja) * 2001-02-01 2002-08-14 Meiji Milk Prod Co Ltd 脂質代謝改善組成物
JP2002255824A (ja) * 2001-02-27 2002-09-11 Meiji Milk Prod Co Ltd 免疫賦活組成物
MY135783A (en) 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US6830766B2 (en) * 2002-03-08 2004-12-14 Mccabe David J. High protein foodstuff
JP4278028B2 (ja) * 2002-12-18 2009-06-10 明治乳業株式会社 炎症性サイトカイン産生抑制活性を有するペプチド
JP5015339B2 (ja) 2011-06-02 2012-08-29 株式会社日本マイクロニクス 液晶パネル点灯検査装置

Also Published As

Publication number Publication date
BR0316512A (pt) 2005-10-04
US20060073186A1 (en) 2006-04-06
NZ540775A (en) 2007-08-31
EP1575379B1 (en) 2010-05-26
CN1741749A (zh) 2006-03-01
JP2013136602A (ja) 2013-07-11
EP1575379A1 (en) 2005-09-21
US20090233865A1 (en) 2009-09-17
DE60332760D1 (de) 2010-07-08
WO2004047566A1 (en) 2004-06-10
JP5688818B2 (ja) 2015-03-25
CN100393243C (zh) 2008-06-11
KR20050083950A (ko) 2005-08-26
JP2011006425A (ja) 2011-01-13
TWI317636B (en) 2009-12-01
DK1575379T3 (da) 2010-09-13
TW200412990A (en) 2004-08-01
KR101038354B1 (ko) 2011-06-01
CA2506603A1 (en) 2004-06-10
US8778404B2 (en) 2014-07-15
CA2506603C (en) 2011-06-28
AU2003283831A1 (en) 2004-06-18
MY169519A (en) 2019-04-22
JP2006515287A (ja) 2006-05-25
ES2344640T3 (es) 2010-09-02
ATE468762T1 (de) 2010-06-15
US7563458B2 (en) 2009-07-21
HK1083174A1 (en) 2006-06-30

Similar Documents

Publication Publication Date Title
AR042107A1 (es) Composiciones dieteticas
UY29195A1 (es) Procesos para la preparacion de composiciones oleosas
MXPA03008823A (es) Metodos, compuestos y composiciones para reducir la grasa corporal y modular el metabolismo de los acidos grasos.
EA200300994A1 (ru) Композиция, исправляющая возрастные физиологические дефициты и увеличивающая продолжительность жизни
CL2004001550A1 (es) Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos.
WO2005120524A3 (en) Nutritional formulations
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
ATE540575T1 (de) Regulatoren des zucker- und lipidstoffwechsels in pflanzen
DE60335708D1 (de) E exprimieren
DK1911442T3 (da) Præparat til forebyggelse og/eller behandling af vaskulære lidelser
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
MX2010006199A (es) Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina.
BRPI0408589A (pt) suplementos dietéticos à base de fruta de açai e juçara
EP1401259A4 (en) -4 DESATURASE GENES AND THEIR USE
PE20151882A1 (es) Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos
MX2010002404A (es) Composiciones de grasa solida que contiene un acido graso poliinsaturado y usos y produccion de las mismas.
DK2021478T3 (da) Delta-5-desaturase og anvendelse heraf i fremstillingen af flerumættede fedtsyrer
EA200970238A1 (ru) ПРИМЕНЕНИЕ МАСЕЛ С DPA(n-6) В ДЕТСКОМ ПИТАНИИ
WO2005046580A3 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
DK2018427T3 (da) Delta-5-desaturase og anvendelse heraf i fremstillingen af flerumættede fedtsyrer
CL2008003212A1 (es) Grasa de leche de rumiante, para su aplicacion en alimentos, con un contenido de acidos grasos saturados menor a 50%, acidos grasos monoinsaturados superior al 47% y acidos grasos poliinsaturados superior a 5,5% sobre la base de acidos grasos totales; procedimiento de obtencion donde se somete a una o mas etapas de fraccionamiento por cristalizacion seguido por fraccionamiento por destilacion molecular.
SE0202529D0 (sv) Food composition product
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
ATE354972T1 (de) Lipid mischungen und lebensmittel, enthaltend ölsäure und omega-6 fettsäuren, die die intramyozelluläre lipidkonzentration erhöhen
WO2004103307A3 (en) Method of use of five and fifteen carbon fatty acids

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee